Victoria Brown - Jan 21, 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Program Team Lead
Signature
/s/ David Watson, attorney-in-fact for Victoria Brown
Stock symbol
APLS
Transactions as of
Jan 21, 2022
Transactions value $
$0
Form type
4
Date filed
1/25/2022, 03:39 PM
Previous filing
Oct 27, 2021
Next filing
Feb 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Award $0 +17.5K +151.22% $0.00 29K Jan 21, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Award $0 +24.8K $0.00 24.8K Jan 21, 2022 Common Stock 24.8K $35.46 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a restricted stock unit grant made on January 21, 2022 that vests 25% annually in equal installments over four years from the date of grant, subject to continued service.
F2 Includes 128 shares from 10/29/21 ESPP purchase.
F3 This represents a non-qualified stock option grant made on January 21, 2022 that vests over a four year period with 25% vesting one year from grant date and the remaining 75% vesting in equal monthly installments thereafter through the fourth anniversary of the grant date, subject to continued service.